Sathianathen NJ, Konety BR, Crook J, Saad F, Lawrentschuk N. Landmarks in prostate cancer. Nat Rev Urol. 2018;15:627–42. https://doi.org/10.1038/s41585-018-0060-7.
Google Scholar
Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP. Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach. Cell Rep Med. 2023;4:101199. https://doi.org/10.1016/j.xcrm.2023.101199.
Google Scholar
Dai B, Wang H, Shi B, Xing J, Zhu S, He Z, et al. CACA guidelines for holistic integrative management of prostate cancer. Holist Integ Oncol. 2024;3:47. https://doi.org/10.1007/s44178-024-00118-4.
Google Scholar
Cha HR, Lee JH, Ponnazhagan S. Revisiting immunotherapy: a focus on prostate cancer. Cancer Res. 2020;80:1615–23. https://doi.org/10.1158/0008-5472.can-19-2948.
Google Scholar
Guan X, Polesso F, Wang C, Sehrawat A, Hawkins RM, Murray SE, et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 2022;606:791–6. https://doi.org/10.1038/s41586-022-04522-6.
Google Scholar
Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, et al. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nat Commun. 2021;12:7041. https://doi.org/10.1038/s41467-021-27349-7.
Google Scholar
Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, et al. CD300ld on neutrophils is required for tumour-driven immune suppression. Nature. 2023;621:830–9. https://doi.org/10.1038/s41586-023-06511-9.
Google Scholar
Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234:8509–21. https://doi.org/10.1002/jcp.27782.
Google Scholar
Pérez-Tomás, R & Pérez-Guillén, I Lactate in the Tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers. 2020;12 https://doi.org/10.3390/cancers12113244.
Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38 https://doi.org/10.1038/s41392-024-02082-x.
Google Scholar
Qian Y, Galan-Cobo A, Guijarro I, Dang M, Molkentine D, Poteete A, et al. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell. 2023;41:1363–80.e1367. https://doi.org/10.1016/j.ccell.2023.05.015.
Google Scholar
Zhao JL, Ye YC, Gao CC, Wang L, Ren KX, Jiang R, et al. Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-Jun axis. Cell Rep. 2022;38:110451. https://doi.org/10.1016/j.celrep.2022.110451.
Google Scholar
Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117:20159–70. https://doi.org/10.1073/pnas.1918986117.
Google Scholar
Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888–902. https://doi.org/10.1016/j.cell.2019.05.031.
Google Scholar
Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289–96. https://doi.org/10.1038/s41592-019-0619-0.
Google Scholar
McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329–37. https://doi.org/10.1016/j.cels.2019.03.003.
Google Scholar
Apodaca MC, Wright AE, Riggins AM, Harris WP, Yeung RS, Yu L, et al. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells. J Immunother Cancer. 2019;7:230 https://doi.org/10.1186/s40425-019-0674-1.
Google Scholar
Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, et al. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Cancer Immunol Immunother. 2019;68:631–44. https://doi.org/10.1007/s00262-018-2170-8.
Google Scholar
Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12:134–53. https://doi.org/10.1158/2159-8290.Cd-21-0316.
Google Scholar
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. https://doi.org/10.1016/j.xinn.2021.100141.
Google Scholar
Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381–6. https://doi.org/10.1038/nbt.2859.
Google Scholar
Vento-Tormo R, Efremova M, Botting R, Turco M, Vento-Tormo M, Meyer K, et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature. 2018;563:347–53. https://doi.org/10.1038/s41586-018-0698-6.
Google Scholar
Li B, Zhang W, Guo C, Xu H, Li L, Fang M, et al. Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution. Nat methods. 2022;19:662–70. https://doi.org/10.1038/s41592-022-01480-9.
Google Scholar
Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004;22:2790–9. https://doi.org/10.1200/jco.2004.05.158.
Google Scholar
Ding Y, Wu H, Warden C, Steele L, Liu X, Iterson MV, et al. Gene expression differences in prostate cancers between young and old men. PLoS Genet. 2016;12:e1006477 https://doi.org/10.1371/journal.pgen.1006477.
Google Scholar
Friedrich M, Wiedemann K, Reiche K, Puppel SH, Pfeifer G, Zipfel I, et al. The role of lncRNAs TAPIR-1 and -2 as diagnostic markers and potential therapeutic targets in prostate cancer. Cancers. 2020;12 https://doi.org/10.3390/cancers12051122.
Kreuz M, Otto DJ, Fuessel S, Blumert C, Bertram C, Bartsch S, et al. ProstaTrend-a multivariable prognostic rna expression score for aggressive prostate cancer. Eur Urol. 2020;78:452–9. https://doi.org/10.1016/j.eururo.2020.06.001.
Google Scholar
Firlej V, Soyeux P, Nourieh M, Huet E, Semprez F, Allory Y, et al. Overexpression of nucleolin and associated genes in prostate cancer. Int J Mol Sci 2022;23 https://doi.org/10.3390/ijms23094491.
Sinha A, Huang V, Livingstone J, Wang J, Fox N, Kurganovs N, et al. The proteogenomic landscape of curable prostate cancer. Cancer cell. 2019;35:414–427. https://doi.org/10.1016/j.ccell.2019.02.005.
Google Scholar
Jain S, Lyons C, Walker S, McQuaid S, Hynes S, Mitchell D, et al. Validation of a metastatic assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Ann Oncol Off J Eur Soc Med Oncol. 2018;29:215–22. https://doi.org/10.1093/annonc/mdx637.
Google Scholar
Chen B, Khodadoust M, Liu C, Newman A, Alizadeh A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–59. https://doi.org/10.1007/978-1-4939-7493-1_12.
Google Scholar
Aran D, Hu Z, Butte A. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220. https://doi.org/10.1186/s13059-017-1349-1.
Google Scholar
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509–W14. https://doi.org/10.1093/nar/gkaa407.
Google Scholar
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550–8. https://doi.org/10.1038/s41591-018-0136-1.
Google Scholar
Antti K, Sini K, E, Heini ML, K, Maria K, et al. Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat Commun. 2024;15 https://doi.org/10.1038/s41467-024-54364-1.
Palla G, Spitzer H, Klein M, Fischer D, Schaar AC, Kuemmerle LB, et al. Squidpy: a scalable framework for spatial omics analysis. Nat Methods. 2022;19:171–8. https://doi.org/10.1038/s41592-021-01358-2.
Google Scholar
Zhong C, Ang KS, Chen J. Interpretable spatially aware dimension reduction of spatial transcriptomics with STAMP. Nat Methods. 2024;21:2072–83. https://doi.org/10.1038/s41592-024-02463-8.
Google Scholar
Jovan, T, Ricardo Omar Ramirez, F, Attila, G, Denis, S & Julio, S-R Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol 2022;23 https://doi.org/10.1186/s13059-022-02663-5.
Hsu P, Scott D, Weinstein J, Ran F, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827–32. https://doi.org/10.1038/nbt.2647.
Google Scholar
Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res: CR. 2020;39:203 https://doi.org/10.1186/s13046-020-01714-8.
Google Scholar
Bronte V, Brandau S, Chen S, Colombo M, Frey A, Greten T, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150. https://doi.org/10.1038/ncomms12150.
Google Scholar
Kai L, Houhui S, Benxia Z, Xuejin O, Qizhi M, Yue C, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6 https://doi.org/10.1038/s41392-021-00670-9.
Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19:108–19. https://doi.org/10.1038/s41590-017-0022-x.
Google Scholar
Chen T, Liu J, Wang C, Wang Z, Zhou J, Lin J, et al. ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia/macrophages. J Immunother Cancer. 2024;12 https://doi.org/10.1136/jitc-2024-009492.
Noman M, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, et al. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211:781–90. https://doi.org/10.1084/jem.20131916.
Google Scholar
Virgo K, Basch E, Loblaw D, Oliver T, Rumble R, Carducci M, et al. Second-Line Hormonal Therapy For Men With Chemotherapy-naïve, Castration-resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion. J Clin Oncol: Off J Am Soc Clin Oncol. 2017;35:1952–64. https://doi.org/10.1200/jco.2017.72.8030.
Google Scholar
Antonarakis E, Piulats J, Gross-Goupil M, Goh J, Ojamaa K, Hoimes C, et al. Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38:395–405. https://doi.org/10.1200/jco.19.01638.
Google Scholar
Hansen A, Massard C, Ott P, Haas N, Lopez J, Ejadi S, et al. Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. Ann Oncol: Off J Eur Soc Med Oncol. 2018;29:1807–13. https://doi.org/10.1093/annonc/mdy232.
Google Scholar
Wu Q, Liang X, Wang K, Lin J, Wang X, Wang P, et al. Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis. Cell Metab. 2021;33:1988–2003. https://doi.org/10.1016/j.cmet.2021.07.007.
Google Scholar
Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, et al. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun. 2024;44:1231–60. https://doi.org/10.1002/cac2.12607.
Google Scholar
Wang L, Liu Y, Dai Y, Tang X, Yin T, Wang C, et al. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment. Gut. 2023;72:958–71. https://doi.org/10.1136/gutjnl-2021-326070.
Google Scholar
Hu Z, Yu X, Ding R, Liu B, Gu C, Pan XW, et al. Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. J Clin Invest. 2023;133 https://doi.org/10.1172/jci166031.
Zhang YT, Xing ML, Fang HH, Li WD, Wu L, Chen ZP. Effects of lactate on metabolism and differentiation of CD4(+)T cells. Mol Immunol. 2023;154:96–107. https://doi.org/10.1016/j.molimm.2022.12.015.
Google Scholar
Kim D, Kim G, Yu R, Lee J, Kim S, Gleason MR, et al. Inhibitory co-receptor Lag3 supports Foxp3(+) regulatory T cell function by restraining Myc-dependent metabolic programming. Immunity. 2024;57:2634–50.e2635. https://doi.org/10.1016/j.immuni.2024.08.008.
Google Scholar
Yasukawa K, Shimada S, Akiyama Y, Taniai T, Igarashi Y, Tsukihara S, et al. ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma. Cell Rep Med. 2025;6:102038. https://doi.org/10.1016/j.xcrm.2025.102038.
Google Scholar
Yan J, Li W, Tian H, Li B, Yu X, Wang G, et al. Metal-phenolic nanomedicines regulate T-cell antitumor function for sono-metabolic cancer therapy. ACS Nano. 2023;17:14667–77. https://doi.org/10.1021/acsnano.3c02428.
Google Scholar
Grover A, Sanseviero E, Timosenko E, Gabrilovich D. Myeloid-derived suppressor cells: a propitious road to clinic. Cancer Discov. 2021;11:2693–706. https://doi.org/10.1158/2159-8290.Cd-21-0764.
Google Scholar
Siska P, Beckermann K, Mason F, Andrejeva G, Greenplate A, Sendor A, et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight, 2017;2. https://doi.org/10.1172/jci.insight.93411.
Peng S, Hu P, Xiao YT, Lu W, Guo D, Hu S, et al. Single-cell analysis reveals EP4 as a target for restoring t-cell infiltration and sensitizing prostate cancer to immunotherapy. Clin Cancer Res. 2022;28:552–67. https://doi.org/10.1158/1078-0432.Ccr-21-0299.
Google Scholar
Werner A, Amann E, Schnitzius V, Habermeier A, Luckner-Minden C, Leuchtner N, et al. Induced arginine transport via cationic amino acid transporter-1 is necessary for human T-cell proliferation. Eur J Immunol. 2016;46:92–103. https://doi.org/10.1002/eji.201546047.
Google Scholar
Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metab. 2018;28:87–103.e106. https://doi.org/10.1016/j.cmet.2018.04.022.
Google Scholar
Xia C, Li M, Ran G, Wang X, Lu Z, Li T, et al. Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy. J Control Release. 2021;335:557–74. https://doi.org/10.1016/j.jconrel.2021.05.034.
Google Scholar
Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer cell. 2022;40:201–18.e209. https://doi.org/10.1016/j.ccell.2022.01.001.
Google Scholar
Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645–51. https://doi.org/10.1038/s41586-020-03045-2.
Google Scholar
Zhang L, Xin C, Wang S, Zhuo S, Zhu J, Li Z, et al. Lactate transported by MCT1 plays an active role in promoting mitochondrial biogenesis and enhancing TCA flux in skeletal muscle. Sci Adv. 2024;10:eadn4508. https://doi.org/10.1126/sciadv.adn4508.
Google Scholar
